UK markets closed
  • FTSE 100

    7,043.61
    +80.28 (+1.15%)
     
  • FTSE 250

    22,336.10
    +266.79 (+1.21%)
     
  • AIM

    1,236.38
    +11.54 (+0.94%)
     
  • GBP/EUR

    1.1602
    -0.0025 (-0.21%)
     
  • GBP/USD

    1.4102
    +0.0050 (+0.36%)
     
  • BTC-GBP

    33,552.03
    -1,891.37 (-5.34%)
     
  • CMC Crypto 200

    1,398.33
    +39.77 (+2.93%)
     
  • S&P 500

    4,173.85
    +61.35 (+1.49%)
     
  • DOW

    34,382.13
    +360.68 (+1.06%)
     
  • CRUDE OIL

    65.51
    +1.69 (+2.65%)
     
  • GOLD FUTURES

    1,844.00
    +20.00 (+1.10%)
     
  • NIKKEI 225

    28,084.47
    +636.46 (+2.32%)
     
  • HANG SENG

    28,027.57
    +308.90 (+1.11%)
     
  • DAX

    15,416.64
    +216.96 (+1.43%)
     
  • CAC 40

    6,385.14
    +96.81 (+1.54%)
     

Britain launches expert group to prepare for future pandemics

Reuters Staff
·1-min read
Surge testing for the coronavirus disease (COVID-19) in the Barnet area of London

By Reuters Staff

LONDON (Reuters) - Britain on Tuesday said it would launch a new international expert group to help bolster the world's preparedness for the next pandemic and expedite the development of vaccines against future diseases when they emerge.

Launched under Britain's Presidency of the Group of Seven (G7) rich nations, the Pandemic Preparedness Partnership (PPP) will report to the G7 leaders summit in June, and will advise on how to achieve Prime Minister Boris Johnson's target of developing vaccines against future diseases within 100 days.

"As G7 President, the UK is determined to work with our partners to build back better from coronavirus and strengthen global preparedness for future pandemics," Health Minister Matt Hancock said ahead of a virtual two-day meeting of the group.

"This new expert group will drive our efforts in the years ahead to protect people everywhere from new diseases and to save lives."

The PPP will be chaired by the UK government's Chief Scientific Adviser Patrick Vallance, and its steering group includes executives from COVID-19 vaccine makers AstraZeneca, Pfizer and Johnson & Johnson as well as scientists.

Britain said there would also be 16 million pounds ($22.37 million) more funding for the Coalition for Epidemic Preparedness Innovations (CEPI) to support global vaccine supply and development.

($1 = 0.7152 pounds)